Clinical Trials Directory

Trials / Completed

CompletedNCT00721903

Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
Female
Age
25 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.

Detailed description

To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasound Scan10 female volunteers with normal breast who will be studied to refine imaging techniques and for comparison with patients. To the degree possible, the volunteer group will be age-matched to patients with symptoms, initially 30 to 70 years of age.
PROCEDUREMammography and UltrasoundTo determine how well from ultrasound scans, changes in malignant masses can be measured, and to whether the use of a dye visible by ultrasound will be useful in evaluating different therapies for breast cancer.

Timeline

Start date
2000-03-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2008-07-25
Last updated
2016-05-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00721903. Inclusion in this directory is not an endorsement.